Exagen
XGN
62 hedge funds and large institutions have $99.5M invested in Exagen in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 10 closing their positions.
1,980% more call options, than puts
Call options by funds: $624K | Put options by funds: $30K
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
85% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 13
55% more capital invested
Capital invested by funds: $64.1M → $99.5M (+$35.4M)
17% more funds holding
Funds holding: 53 → 62 (+9)
0.95% less ownership
Funds ownership: 42.09% → 41.14% (-0.95%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$5.98M |
| 2 |
Millennium Management
New York
|
+$2.19M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.14M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.79M |
| 5 |
Two Sigma Investments
New York
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$7.36M |
| 2 |
Morgan Stanley
New York
|
-$4.27M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.36M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.15M |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.88M |
XGN Hedge Fund Activity: Q3 2025 in Review
62 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q3 2025, worth a combined $99.5M — up 55% from $64.1M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new XGN positions and 10 closed out — a net gain of 9 holders — while 24 added to existing stakes and 13 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $5.98M. The largest seller was Toronto Dominion Bank, cutting an estimated $7.36M.
- 62 institutional investors held Exagen (XGN) as of Q3 2025, up from 53 in Q2 2025.
- Funds reported $99.5M of Exagen stock for Q3 2025, up 55% quarter-over-quarter.
- 19 funds opened new Exagen positions in Q3 2025 and 10 closed out, a net change of +9 holders.
- The largest Exagen buyer in Q3 2025 was Invesco, an estimated $5.98M added.
- The largest Exagen seller in Q3 2025 was Toronto Dominion Bank, an estimated $7.36M sold.
Based on aggregated 13F filings for Q3 2025.